These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33084098)

  • 1. Factors associated with registrant availability for unrelated adult donor hematopoietic stem cell donation: Analysis of the stem cell registry at Canadian Blood Services.
    Monaghan M; Yi QL; Green M; Campbell T; Weiss JT; Dibdin N; Mercer D; Elmoazzen H; Allan DS
    Transfusion; 2021 Jan; 61(1):24-28. PubMed ID: 33084098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted recruitment of optimal donors for unrelated hematopoietic cell transplantation: The Stem Cell Club process.
    Fingrut W; Messner HA; Allan D
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):220-231. PubMed ID: 32387075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups.
    Blake JT; Parmar G; Ganz K; Seftel MD; Allan DS
    Transfusion; 2023 May; 63(5):1060-1066. PubMed ID: 36961333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor selection process for allogeneic hematopoietic stem cell transplantation at the university hospital of Düsseldorf (1997-1998).
    Enczmann J; Rinker M; Kiesel U; Kuhröber A; Kögler G; Nürnberger W; Göbel U; Wernet P
    Klin Padiatr; 1999; 211(4):218-23. PubMed ID: 10472554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association.
    Hurley CK; Wade JA; Oudshoorn M; Middleton D; Kukuruga D; Navarrete C; Christiansen F; Hegland J; Ren EC; Andersen I; Cleaver SA; Brautbar C; Raffoux C
    Hum Immunol; 1999 Apr; 60(4):347-60. PubMed ID: 10363727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach.
    Tiercy JM; Stadelmann S; Chapuis B; Gratwohl A; Schanz U; Seger RA; Faveri GN; Kern M; Morell A; Schwabe R; Schneider P
    Bone Marrow Transplant; 2003 Sep; 32(6):623-7. PubMed ID: 12953136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
    Kindwall-Keller TL; Ballen KK
    Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to select the best available related or unrelated donor of hematopoietic stem cells?
    Tiercy JM
    Haematologica; 2016 Jun; 101(6):680-7. PubMed ID: 27252513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor registries and search strategies.
    Hurley CK; Oudshoorn M; Setterholm M
    Methods Mol Biol; 2012; 882():531-47. PubMed ID: 22665254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-haplotype redundancy and rareness in Canadian Blood Services' Stem Cell Registry and Cord Blood Bank: Novel metrics for optimizing utility.
    Bailey AJM; Blake J; Ganz K; Seftel MD; Allan DS
    Transfusion; 2023 Nov; 63(11):2114-2119. PubMed ID: 37750668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Discrepancies between human leukocyte antigen registry typing and confirmatory typing results of unrelated hematopoietic stem cell donors].
    Ko DH; Chung HY; Lim YM; Han BY; Song EY; Park MH
    Korean J Lab Med; 2010 Dec; 30(6):668-74. PubMed ID: 21157155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.
    Gragert L; Eapen M; Williams E; Freeman J; Spellman S; Baitty R; Hartzman R; Rizzo JD; Horowitz M; Confer D; Maiers M
    N Engl J Med; 2014 Jul; 371(4):339-48. PubMed ID: 25054717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection.
    Greco-Stewart V; Kiernan J; Killeen D; Haun S; Mercer D; Young K; Liwski RS; Allan DS
    Transfusion; 2018 Mar; 58(3):718-725. PubMed ID: 29277913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for new donor typing based on donor HLA type or donor characteristics.
    Little AM; Jindra P; Raffoux C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():8-9. PubMed ID: 17445153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved access to better HLA-matched hematopoietic cells for allogeneic transplant: analysis of donors and cord blood units selected for Canadian patients in 2018.
    Greco-Stewart V; Elmoazzen H; Morris G; Guo Y; Langdon C; Mercer D; Dibdin N; Allan DS
    Transfusion; 2020 Jul; 60(7):1508-1518. PubMed ID: 32319688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis.
    Allan DS; Green M; Morris G; Weiss J; Dibdin N; Mercer D; Seftel M
    Vox Sang; 2022 Sep; 117(9):1121-1125. PubMed ID: 35583125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors.
    Hurley CK; Wade JA; Oudshoorn M; Middleton D; Kukuruga D; Navarrete C; Christiansen F; Hegland J; Ren EC; Andersen I; Cleaver SA; Brautbar C; Raffoux C
    Tissue Antigens; 1999 Apr; 53(4 Pt 1):394-406. PubMed ID: 10323348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attrition at the final donor stage among unrelated haematopoietic stem cell donors: the British Bone Marrow Registry experience.
    Balassa K; Griffiths A; Winstone D; Li Y; Rocha V; Pawson R
    Transfus Med; 2019 Oct; 29(5):332-337. PubMed ID: 31209947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenetics in stem cell donor registry work: The DKMS example (Part 1).
    Schmidt AH; Sauter J; Baier DM; Daiss J; Keller A; Klussmeier A; Mengling T; Rall G; Riethmüller T; Schöfl G; Solloch UV; Torosian T; Means D; Kelly H; Jagannathan L; Paul P; Giani AS; Hildebrand S; Schumacher S; Markert J; Füssel M; Hofmann JA; Schäfer T; Pingel J; Lange V; Schetelig J
    Int J Immunogenet; 2020 Feb; 47(1):13-23. PubMed ID: 31903698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the impact of current Canadian stem cell registry policy on donor availability via dynamic registry simulation.
    Blake JT; Ganz K; Seftel M; Allan D
    Vox Sang; 2024 Jun; 119(6):598-605. PubMed ID: 38523418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.